DE2543535C3 - 1 -N-(a-Hydroxy-co-aminoalkanoyl) -6'-N-methyl-3',4'-didesoxy-kanamycine B, deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zur Herstellung derselben und Arzneimittel - Google Patents

1 -N-(a-Hydroxy-co-aminoalkanoyl) -6'-N-methyl-3',4'-didesoxy-kanamycine B, deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zur Herstellung derselben und Arzneimittel

Info

Publication number
DE2543535C3
DE2543535C3 DE2543535A DE2543535A DE2543535C3 DE 2543535 C3 DE2543535 C3 DE 2543535C3 DE 2543535 A DE2543535 A DE 2543535A DE 2543535 A DE2543535 A DE 2543535A DE 2543535 C3 DE2543535 C3 DE 2543535C3
Authority
DE
Germany
Prior art keywords
hydroxy
methyl
mixture
dideoxykanamycin
kanamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2543535A
Other languages
German (de)
English (en)
Other versions
DE2543535B2 (de
DE2543535A1 (de
Inventor
Shinji Yokokama Kanagawa Kondo
Kenji Maeda
Hamao Umezawa
Sumio Tokio Umezawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of DE2543535A1 publication Critical patent/DE2543535A1/de
Publication of DE2543535B2 publication Critical patent/DE2543535B2/de
Application granted granted Critical
Publication of DE2543535C3 publication Critical patent/DE2543535C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Vapour Deposition (AREA)
DE2543535A 1974-10-08 1975-09-30 1 -N-(a-Hydroxy-co-aminoalkanoyl) -6'-N-methyl-3',4'-didesoxy-kanamycine B, deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zur Herstellung derselben und Arzneimittel Expired DE2543535C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49115199A JPS5148634A (en) 1974-10-08 1974-10-08 Taiseikinnyukona 11nn * arufua hidorokishi omega aminoashiru * 6**nn mechiru 3* *hh jideokishikanamaishin b no seizoho

Publications (3)

Publication Number Publication Date
DE2543535A1 DE2543535A1 (de) 1976-04-22
DE2543535B2 DE2543535B2 (de) 1977-10-13
DE2543535C3 true DE2543535C3 (de) 1978-06-01

Family

ID=14656799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2543535A Expired DE2543535C3 (de) 1974-10-08 1975-09-30 1 -N-(a-Hydroxy-co-aminoalkanoyl) -6'-N-methyl-3',4'-didesoxy-kanamycine B, deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zur Herstellung derselben und Arzneimittel

Country Status (16)

Country Link
JP (1) JPS5148634A (US08087162-20120103-C00010.png)
BE (1) BE834236A (US08087162-20120103-C00010.png)
CA (1) CA1050537A (US08087162-20120103-C00010.png)
CH (1) CH615685A5 (US08087162-20120103-C00010.png)
DE (1) DE2543535C3 (US08087162-20120103-C00010.png)
DK (1) DK148262C (US08087162-20120103-C00010.png)
FR (1) FR2287233A1 (US08087162-20120103-C00010.png)
GB (1) GB1475481A (US08087162-20120103-C00010.png)
HU (1) HU173702B (US08087162-20120103-C00010.png)
IE (1) IE42354B1 (US08087162-20120103-C00010.png)
LU (1) LU73533A1 (US08087162-20120103-C00010.png)
NL (1) NL181503C (US08087162-20120103-C00010.png)
SE (1) SE431216B (US08087162-20120103-C00010.png)
SU (1) SU965359A3 (US08087162-20120103-C00010.png)
YU (1) YU39659B (US08087162-20120103-C00010.png)
ZA (1) ZA756291B (US08087162-20120103-C00010.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57175198A (en) * 1981-04-20 1982-10-28 Microbial Chem Res Found 1-n-acyl derivative of 5,3,4-trideoxy-6-n-methylkanamycin b and their preparation
JPS60179468U (ja) * 1984-05-11 1985-11-28 大成プラス株式会社 多色スタンプ
DE102006004062A1 (de) 2006-01-28 2007-08-09 Degussa Gmbh Kautschukmischungen
WO2007142150A1 (ja) 2006-06-02 2007-12-13 Meiji Seika Kaisha, Ltd. 新規アミノグリコシド系抗生物質

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001208A (en) * 1972-10-06 1977-01-04 Zaidan Hojin Biseibutsu Kagaku Kenkyo Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl]

Also Published As

Publication number Publication date
YU253075A (en) 1982-05-31
IE42354L (en) 1976-04-08
JPS5148634A (en) 1976-04-26
IE42354B1 (en) 1980-07-30
HU173702B (hu) 1979-07-28
NL181503C (nl) 1987-09-01
ZA756291B (en) 1976-06-30
DE2543535B2 (de) 1977-10-13
JPS5653558B2 (US08087162-20120103-C00010.png) 1981-12-19
YU39659B (en) 1985-03-20
CH615685A5 (en) 1980-02-15
LU73533A1 (US08087162-20120103-C00010.png) 1976-08-19
DK148262C (da) 1986-02-10
GB1475481A (en) 1977-06-01
NL7511662A (nl) 1976-04-12
SU965359A3 (ru) 1982-10-07
DK148262B (da) 1985-05-20
FR2287233B1 (US08087162-20120103-C00010.png) 1978-11-10
DK451475A (da) 1976-04-09
DE2543535A1 (de) 1976-04-22
BE834236A (fr) 1976-04-06
SE7511229L (sv) 1976-04-09
NL181503B (nl) 1987-04-01
SE431216B (sv) 1984-01-23
CA1050537A (en) 1979-03-13
AU8518975A (en) 1977-03-31
FR2287233A1 (fr) 1976-05-07

Similar Documents

Publication Publication Date Title
DE2440956C3 (de) Kanamycin B-Derivate, Verfahren zu ihrer Herstellung und solche Derivate enthaltende Arzneimittel
DE2350169C3 (de) 19.10.72 Japan 103988-72 11.12.72 Japan 123482-72 23.01.73 Japan 9146-73 1-N- [(S)-2-Hydroxy-4-amino-butyryl] -neamin-Derivate, Verfahren zu ihrer Herstellung und solche Derivate enthaltende Arzneimittel
DE2332485C2 (de) Gentamicin C1-derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2130113B2 (de) Gentamicin B, Gentamicin B1 und Gentamicin X, Verfahren zu deren Gewinnung und diese Gentamicine enthaltende pharmazeutische Zubereitungen
DE2411504C3 (de) 6'-Substituierte 6'-Desoxylividomycine B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3881576T2 (de) Anthracyclinderivate und ihre Verwendung.
DE1935967C3 (de) Naphthacenderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE2724597C3 (de) 3'-Desoxykanamycin C und 3\4'-Didesoxykanamycin C, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE2804508C2 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung als antibakterielle Wirkstoffe
DE2618009C3 (de) 1-N-<a-Hydroxy-to-aminoacyl)- derivate des 3'-Deoxykanamycin A und diese enthaltende Arzneimittel
DE2350203B2 (de) Verfahren zur Herstellung von 1-N- [(S) -2-Hydroxy-4-amino- butyryl] -neamin, -3', 4'-didesoxyneamin,-ribostamycin oder -3',4' -didesoxyribostamycin
DE2543535C3 (de) 1 -N-(a-Hydroxy-co-aminoalkanoyl) -6'-N-methyl-3',4'-didesoxy-kanamycine B, deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zur Herstellung derselben und Arzneimittel
DE2423591C3 (de) 1-N-Isoserylkanamycine, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel
DE2458921C3 (de) N-(2-Hydroxy-4-aminobutyryl)-Derivate des Antibiotikums XK-62-2, ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2825289B2 (de) Kanamycinen und Ribostamycinen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE3112124A1 (de) Neue derivate der istamycin a und b und verfahren zur herstellung derselben
DE3227178C2 (de) 2'-Modifizierte Kanamycine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE2512587C3 (de) 1 -N-(L-4-Amino-2-hydroxybutyryl)-6' -N-alkylkanamycine A, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2352361A1 (de) Antibiotische derivate
DE3004178C2 (US08087162-20120103-C00010.png)
DE2437159C2 (de) Mutamicine 1, 2, 4, 5 und 6, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CH646714A5 (de) Aprosamin-derivate.
US3743634A (en) 2-deoxystreptamine derivative and acid-addition salts
DE2759475C2 (de) Verfahren zur Herstellung von Kanamycin C
DE2908150C2 (de) Fortimicin KG↓1↓, KG↓2↓ und KG↓3↓ Verfahren zu ihrerHerstellung und pharmazeutische Zubereitung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee